Xenon Pharmaceuticals
XENE
XENE
129 hedge funds and large institutions have $1.44B invested in Xenon Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 50 increasing their positions, 27 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
31% more call options, than puts
Call options by funds: $6.15M | Put options by funds: $4.71M
9.51% more ownership
Funds ownership: 82.93% → 92.44% (+9.5%)
9% more funds holding
Funds holding: 118 → 129 (+11)
Holders
129
Holding in Top 10
5
Calls
$6.15M
Puts
$4.71M
Top Buyers
| 1 | +$59.8M | |
| 2 | +$53.7M | |
| 3 | +$50.3M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$44.3M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$41.7M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$15.9M | |
| 3 | -$15.2M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$14.6M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$8.03M |